NCT06744296View on ClinicalTrials.gov

Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck

RecruitingOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

February 3, 2025

Primary Completion Date

January 6, 2027

Study Completion Date

January 6, 2029

Conditions
Squamous Cell Carcinoma of Head and Neck
Interventions
OTHER

Blood Draws and Tissue Sample(s)

All participants on the study, regardless of arm, will be getting blood draws, and tissue samples.

Trial Locations (1)

02114

RECRUITING

Massachusetts Eye and Ear, Boston

All Listed Sponsors
collaborator

Haystack Oncology, Inc.

UNKNOWN

lead

Massachusetts Eye and Ear Infirmary

OTHER